GLP-1 RECEPTOR AGONIST AND USE THEREOF

Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Heo, Jaeho, Oh, Changmok, Jang, Eun Hye, Kwon, Sung Wook, Kim, Jeong-Geun, Kim, Gunhee, Jeon, Woo Jin, Je, In-gyu, Choi, Ji Hye, Yoo, Yeongran, Hong, Changhee, Jun, Yearin, Shin, Jae Eui, Lee, myong Jae, Im, A-rang, Jeong, Jin Ah, Mi, Kyung, Chang, Min Whan, Park, Jung-Eun, Sohn, Te-ik, Lee, Jin Hee, Kim, Kyeojin, Yoon, Hong Chul, Hong, Da Hae, Kim, Jung Ho
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.